Live Breaking News & Updates on Radiographic Progression With

Stay updated with breaking news from Radiographic progression with. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Data Show Patients Treated with First-in-Class TREMFYA® (guselkumab) Achieve Durable Efficacy Across Joint and Axial Symptoms of Active Psoriatic Arthritis Through Two Years

/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from Phase 3 studies demonstrating patients treated with. ....

United States , University Of Washington , Spring House , British Columbia , Donvitot Creakyjoints , Terence Rooney , Philip Mease , Bridget Kimmel , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Swedish Medical Center Providence , National Psoriasis Foundation , None Of The Janssen Pharmaceutical Companies , Form Health Survey Physical Component Summary , European Congress , Joseph Health , Drug Administration , Health Assessment Questionnaire , Guselkumab Provides Sustained Improvements In Health , Exchange Commission , Companies Of Johnson , Group For Research , Swedish Medical , Efficacy Across Joint , Psoriatic Arthritis ,